Metrifonate. A viewpoint.
Giacobini
E
E
Department of Geriatrics, University of Geneva Medical School, Switzerland.
D000109:Acetylcholine / Q000378:metabolism; D000544:Alzheimer Disease / Q000188:drug therapy*; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D004298:Dopamine / Q000378:metabolism; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D009638:Norepinephrine / Q000378:metabolism; D012552:Schistosomiasis / Q000188:drug therapy*; D014236:Trichlorfon / Q000627:therapeutic use*
D000871:Anthelmintics; D002800:Cholinesterase Inhibitors; D014236:Trichlorfon; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine